Meeting: Cancer R&D
Presenter Lauren V. Wood, M.D.
Abstract: Versamune® (R-D0TAP): A Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens
Session: Immunotherapy in Cancer
Date: Monday, October 26, 2020
Time: 11:00 a.m. ET
Receive Email Alerts
Join our mailing list to receive the latest news and updates from our team.
